EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/20/2024
Back to search
Official data from USPTO
VERITAS IN SILICO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
VERITAS IN SILICO
ST13
US500000079295799Class
1, 5, 40, 41, 42
Filing
79295799
Registration
6848721
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
08/20/2024
Trademark type
Word
Nice classes
1, 5, 40, 41, 42
Filing date
06/05/2020
Registration date
09/20/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/20/2022
Last transaction
08/20/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
OSGOOD, KRYSTINA
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Veritas In Silico Inc.
Representatives
Sean K. Owens Wood Herron & Evans LLP
Technical classification
Nice Classes
Class 1Class 5Class 40Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalsnamely chemicals for use in medical industry and medical science; small molecule compounds as chemicals for use in medical science and medical industry; nucleic acids for laboratory use excluding the use in industrial chemistryother than for medical or veterinary purposes; nucleic acid chemical reagents excluding the use in research or development in industrial chemistryother than for medical or veterinary purposes; reagents and assays for use in scientificmedical or drug discovery research; reagents for chemical analysesexcluding the use in research or development in industrial chemistryother than for medical or veterinary purposes; reagents for nucleic acid isolation and purification for medical and drug discovery research purposes; reagents for nucleic acid synthesis and analysis for medical and drug discovery research purposes; diagnostic preparations and assay samples for medical and drug discovery researchclinical researchlaboratory useother than for medical or veterinary purposes; proteins in raw material form and enzymes for scientific and medical research purposes; cells for research or scientific purposes; nucleic acidDNA deoxyribonucleic acids for laboratory use; nucleic acidRNA ribonucleic acids for laboratory use; antibodiesantibody reagents for research useother than for medical or veterinary purposes; artificial sweeteners; raw materialsunprocessed plastics in all forms; none of the foregoing for use in research or development in industrial chemistry
Class 5
Pharmaceutical preparations targeting messenger RNA or other types of RNA for the treatment of autoimmuneautoinflammatory diseasesbacterial infectionsbehavioral and mental disordersblood diseaseschromosome disorderscongenital and genetic diseasesconnective tissue diseasesdigestive diseasesear diseasesnose diseasesthroat diseasesendocrine diseasesenvironmental diseaseseye diseasesfemale reproductive diseasesfungal infectionsheart diseaseshereditary cancer syndromesimmune system diseaseskidney and urinary diseaseslung diseasesmale reproductive diseasesmetabolic disordersmouth diseasesmusculoskeletal diseasesmyelodysplastic syndromesnervous system diseasesnewborn screeningnutritional diseasesparasitic diseasesrare cancersrare diseasesskin diseases and viral infections; reagent paper for medical purposes; pharmaceutical preparations targeting messenger RNA or other types of RNAother than for agricultural purposes for the treatment of autoimmuneautoinflammatory diseasesbacterial infectionsbehavioral and mental disordersblood diseaseschromosome disorderscongenital and genetic diseasesconnective tissue diseasesdigestive diseasesear diseasesnose diseasesthroat diseasesendocrine diseasesenvironmental diseaseseye diseasesfemale reproductive diseasesfungal infectionsheart diseaseshereditary cancer syndromesimmune system diseaseskidney and urinary diseaseslung diseasesmale reproductive diseasesmetabolic disordersmouth diseasesmusculoskeletal diseasesmyelodysplastic syndromesnervous system diseasesnewborn screeningnutritional diseasesparasitic diseasesrare cancersrare diseasesskin diseases and viral infections; drugs for medical purposestargeting messenger RNA or other types of RNA for the treatment of autoimmuneautoinflammatory diseasesbacterial infectionsbehavioral and mental disordersblood diseaseschromosome disorderscongenital and genetic diseasesconnective tissue diseasesdigestive diseasesear diseasesnose diseasesthroat diseasesendocrine diseasesenvironmental diseaseseye diseasesfemale reproductive diseasesfungal infectionsheart diseaseshereditary cancer syndromesimmune system diseaseskidney and urinary diseaseslung diseasesmale reproductive diseasesmetabolic disordersmouth diseasesmusculoskeletal diseasesmyelodysplastic syndromesnervous system diseasesnewborn screeningnutritional diseasesparasitic diseasesrare cancersrare diseasesskin diseases and viral infections; biological preparations for medical purposestargeting messenger RNA or other types of RNA for the treatment of autoimmuneautoinflammatory diseasesbacterial infectionsbehavioral and mental disordersblood diseaseschromosome disorderscongenital and genetic diseasesconnective tissue diseasesdigestive diseasesear diseasesnose diseasesthroat diseasesendocrine diseasesenvironmental diseaseseye diseasesfemale reproductive diseasesfungal infectionsheart diseaseshereditary cancer syndromesimmune system diseaseskidney and urinary diseaseslung diseasesmale reproductive diseasesmetabolic disordersmouth diseasesmusculoskeletal diseasesmyelodysplastic syndromesnervous system diseasesnewborn screeningnutritional diseasesparasitic diseasesrare cancersrare diseasesskin diseases and viral infections; nucleic acid sequences for medical and veterinary purposes; cells for medical purposes; blood for medical purposes; diagnostic and therapeutic antibodies for medical purposes; vaccines; enzyme inhibitorsonly for medical or veterinary purposes; medical assay preparations for therapeutic or diagnostic purposes; medical diagnostic reagents; reagents for medical purposes; reagents for extracting nucleic acidsonly for medical or veterinary diagnostic purposes; pharmaceutical preparations containing nucleic acidstargeting messenger RNA or other types of RNA for the treatment of autoimmuneautoinflammatory diseasesbacterial infectionsbehavioral and mental disordersblood diseaseschromosome disorderscongenital and genetic diseasesconnective tissue diseasesdigestive diseasesear diseasesnose diseasesthroat diseasesendocrine diseasesenvironmental diseaseseye diseasesfemale reproductive diseasesfungal infectionsheart diseaseshereditary cancer syndromesimmune system diseaseskidney and urinary diseaseslung diseasesmale reproductive diseasesmetabolic disordersmouth diseasesmusculoskeletal diseasesmyelodysplastic syndromesnervous system diseasesnewborn screeningnutritional diseasesparasitic diseasesrare cancersrare diseasesskin diseases and viral infections; reagents for detectionidentificationanalysis and quantification of nucleic acids for pharmaceutical and diagnostic medical purposes; enzymes for medical purposes; lacteal flour for babies; dietary supplements for humans; dietetic foods in liquid form adapted for medical purposes; dietetic foods adapted for medical purposes; beveragesdietetic foods in the form of liquid for babies; food for babies; dietary supplements for animals
Class 40
Custom manufacturing of pharmaceuticals for others; custom synthesis in the nature of custom manufacturing of nucleic acids for others for use in medicines and pharmaceutical preparations; custom extractionpurificationsynthesiscustom manufacturing of pharmaceuticals for others by utilizing genome editing or gene editing technology; custom synthesis in the nature of custom manufacturing of chemical compounds for others for use in medicines and pharmaceutical preparations; custom synthesis in the nature of custom manufacturing of chemical compounds for others; providing material treatment information; printing
Class 41
Educational and instruction servicesorganizing events for educational and teaching purposes relating to artscraftssports and general knowledge; teaching in the field of drug discovery and development; educating at universities and graduate schools; arrangingconducting and organization of seminars; arrangingconducting and organization of symposiumslecture meetingsworkshops and study groups; arrangingconducting and organization of educational seminarssymposiumslecture meetingsworkshops and study groups in the field of drug discovery and development; providing online non-downloadable electronic publications in the nature of magazinesnewslettersjournals and books in the field of nucleic acidspharmaceuticalsdrug discovery and developmentmedicinechemicals and engineering; reference libraries of literature and documentary records; book rental; providing online musicsound recordingsvideos featuring information and instruction on nucleic acidspharmaceuticalsdrug discovery and developmentmedicinechemicals and engineeringimages and character text informationnon-downloadable; educational services in the nature of providing exhibits of academic materials in the field of nucleic acidspharmaceuticalsdrug discovery and developmentmedicinechemicals and engineering; art exhibitions; publication of books; movie theatre presentationsmovie showing and movie film production and distribution; production of videotape film in the field of educationcultureentertainment or sportsnot for movies or television programs and not for advertising or publicity
Class 42
Custom design of chemical reagents and biological assays for use in medicines and engineering design servicesnot for advertising; development of pharmaceutical preparations and medicines; computer software designcomputer programmingmaintenance of computer software for use in RNA targeted drug discovery and development; designingprogramming and maintenance of computer software having artificial intelligence functionality for use in RNA targeted drug discovery and development; computer software designcomputer programmingmaintenance of computer software for use in scientific and technical analysis of data from artificial intelligence for use in RNA targeted drug discovery and development; computer software designcomputer programmingmaintenance of computer software for use in analysistestingscreeningdesigningdevelopment or research on nucleic acidspharmaceuticals or chemicals for use in medicines for use in RNA targeted drug discovery and development; computer software designcomputer programmingmaintenance of computer software for use in drug discovery screening; computer software designcomputer programmingmaintenance of computer software for use in genome research or treatmentspharmaceutical preparations for RNA targeted drug discovery and development; technological advice relating to computersautomobiles and other industrial machines requiring highly specialized knowledgeskills and experiences for proper operationcomputer technology consultancy and industrial machine part design consulting for use in RNA targeted drug discovery and development; scientific researchtesting and analysis in the field of nucleic acidspharmaceuticalsdrug discovery and developmentmedicineschemicals and engineering for use in RNA targeted drug discovery and development; quality control assessment services for use in RNA targeted drug discovery and development for others; testinginspection or research of pharmaceuticals for use in RNA targeted drug discovery and development; providing information and consultancy on testinginspection or research of pharmaceuticalschemicals for use in medicinesreagents for use in medicines for use in RNA targeted drug discovery and development; scientific or laboratory testinginspection or research of nucleic acidschemicals and pharmaceuticals for drug development and medical research purposesproviding scientific information and research consultancy relating thereto for use in RNA targeted drug discovery and development; testing or scientific research on biotechnology and providing scientific information and research consultancy relating thereto for use in RNA targeted drug discovery and development; genomic experimentsanalysesresearchassaystestsinspectiondetection or verificationscientific genomic analysesscientific genomic researchcustom design and development of biochemical genomic assaysgenome amplification and functional and structural analysis of genomes for use in RNA targeted drug discovery and development; scientific research consultancyadvice and providing scientific research information in the field of genomic experimentsanalysesresearchassaystestsinspectiondetection or verification for use in RNA targeted drug discovery and development; scientific and technological servicestestinganalysis surveyingresearch or data analysis in the field of biomedicinegenome biologypharmacogenomicsdiagnosticsclinical trials and bioengineering for use in RNA targeted drug discovery and development; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceuticals for use in RNA targeted drug discovery and development for others; rental of computers; providing computer programs on data networksproviding temporary use of non-downloadable computer software for enablingsupporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acidspharmaceuticalsmedicines and chemicals; providing temporary use of non-downloadable computer software having artificial intelligence functionality on data networks for enablingsupporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acidspharmaceuticalsmedicines and chemicals; providing online non-downloadable computer software for analyzing science and technology data based on artificial intelligence (AI) technology for use in RNA targeted drug discovery and development; providing online non-downloadable computer software for analyzingtestingscreeningdesigningdeveloping and researching of nucleic acidspharmaceuticals and chemicals for use in RNA targeted drug discovery and development; providing online non-downloadable computer software for drug discovery screening; providing online non-downloadable computer software for conducting and accessing genome research and treatmentspharmaceutical preparations for use in RNA targeted drug discovery and development
Publications
History of USPTO decisions and trademark events.
51 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/20/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/20/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/20/2024
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
01/23/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/25/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/15/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/22/2022
FIMP
FINAL DISPOSITION PROCESSED
12/22/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/20/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/11/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/20/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/20/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
08/14/2022
CHPB
POST PUBLICATION AMENDMENT - ENTERED
05/25/2022
APET
ASSIGNED TO PETITION STAFF
05/24/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
05/10/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
04/28/2022
GPNX
NOTIFICATION PROCESSED BY IB
04/10/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/10/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/05/2022
PUBO
PUBLISHED FOR OPPOSITION
04/05/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/23/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/23/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/16/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/16/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/16/2022
LOPR
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
03/02/2022
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
02/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/28/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/20/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/20/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/20/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/24/2021
GNRT
NON-FINAL ACTION E-MAILED
06/24/2021
CNRT
NON-FINAL ACTION WRITTEN
06/24/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2021
RFNT
REFUSAL PROCESSED BY IB
11/29/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/12/2020
RFRR
REFUSAL PROCESSED BY MPU
11/12/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/23/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/22/2020
CNRT
NON-FINAL ACTION WRITTEN
10/21/2020
DOCK
ASSIGNED TO EXAMINER
10/19/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/19/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/15/2020
Continuous trademark protection
Get notified about every new filing that threatens VERITAS IN SILICO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.